Long COVID Studies

RECOVER ENERGIZE Study

Brief Summary:

ClinicalTrials.gov Identifier NCT06404047

The goal of the study is to find ways to improve the lives of people with exercise intolerance or PEM. With your help, we want to find out if personalized cardiopulmonary rehabilitation (a program to improve your ability to exercise) or structured pacing (a program to help reduce symptoms of PEM) can improve daily functioning. With your help, we can better understand how COVID affects energy levels and find ways to help improve daily functioning for people with Long COVID.

To qualify, you must meet the following inclusion criteria:

•  You are an adult )age 18 or higher) who had COVID at least 3 months ago • After COVID, you now have: shortness of breath or fatigue during physical activity or – worsened symptoms even after minor physical, mental, or emotional activity

If you qualify and choose to join the study, you will receive:

• Evaluations from a licensed physician
• The rehabilitation, pacing program, or control group.
• All  study-related visits and tests at no cost
• Compensation for your time and effort

Please contact us to learn more.

RECOVER VITAL Study

Brief Summary:

ClinicalTrials.gov Identifier NCT05595369

This is study evaluates the effect of 15 and 25 days of a drug (Paxlovid) compared to placebo in Long COVID patients with fatigue, brain fog, and autonomic function. Participants will be randomized to study interventions or placebo/controls based on the arms that are actively enrolling at the time of randomization. Study interventions may be added or removed according to adaptive design and/or emerging evidence. When there are multiple study interventions available, randomization will occur based on appropriateness of each intervention for the participant as determined by the study protocol.

To qualify, you must meet the following inclusion criteria:

• Long Haul COVID Infection (Documented by PCR or patient report)
• Age >= 18 years old
• At least 12 weeks since the initial COVID Infection
• One or more of the following symptom/signs: Brain Fog, Exhaustion, Low Energy, Dizziness, Shortness of Breath, Upset Stomach

If you qualify and choose to join the study, you will receive:

• Evaluations from a licensed physician
• The rehabilitation program and all study-related visits and tests at no cost
• Compensation for your time and effort

Please contact us to learn more.

RECOVER NEURO Study

Brief Summary:

ClinicalTrials.gov Identifier NCT05965752

This study studies the effect of cognitive retraining, goal management, and transcranial stimulation on brain function in Long COVID. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating potential interventions for PASC-mediated cognitive dysfunction. The hypothesis is that PASC-mediated declines in cognitive domains, such as executive function and attention, may be improved by interventions that selectively focus on enhancing those domains.

To qualify, you must meet the following inclusion criteria:

• Long Haul COVID Infection (Documented by PCR or patient report)
• Age >= 18 years old
• At least 12 weeks since the initial COVID Infection
• One or more of the following symptom/signs: Brain Fog, and/or Trouble Paying Attention Or Remembering Things.

If you qualify and choose to join the study, you will receive:

• Evaluations from a licensed physician
• The rehabilitation program and all study-related visits and tests at no cost
• Compensation for your time and effort

Please contact us to learn more.

For Clinical Trial Recruitment